Northann Corp. (NCL)
USD 0.28
(-3.45%)
USD 0.28
(-3.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -4.67 Million | -3.64 Million | 4.55 Million | -897.89 Thousand |
| Net Income | -7.13 Million | 929.05 Thousand | 322.68 Thousand | 444.09 Thousand |
| Depreciation & Amortization | 680.16 Thousand | 598.14 Thousand | 815.95 Thousand | 863.09 Thousand |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | - | - | - |
| Change in working capital | 1.75 Million | -5.48 Million | 3.4 Million | -2.2 Million |
| Other non-cash items | 13.89 Thousand | 313.69 Thousand | 13.89 Thousand | -1.21 Million |
| Investing Cash Flow | - | -150.6 Thousand | -1.31 Million | -758.71 Thousand |
| Investments in PPE | -4.00 | -487.27 Thousand | -1.31 Million | -758.71 Thousand |
| Acquisitions | - | 336.66 Thousand | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | - | 336.66 Thousand | -53.01 Thousand | -161.16 Thousand |
| Financing Cash Flow | 5.37 Million | 2.77 Million | -3.13 Million | 2.14 Million |
| Debt repayment | -1.3 Million | -1.69 Million | -1.76 Million | -782.43 Thousand |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 5.96 Million | - | - | - |
| Other Financing Activities | 118.88 Thousand | 2.77 Million | -3.13 Million | 2.14 Million |
| Accounts receivables | -1.18 Million | -174.32 Thousand | -1.15 Million | -113.88 Thousand |
| Accounts payables | -2.38 Million | -1.48 Million | 3.19 Million | -1.38 Million |
| Inventory | 1.91 Million | -1.7 Million | -594.02 Thousand | -1.34 Million |
| Other working capital | 3.41 Million | -2.12 Million | 1.95 Million | 634.63 Thousand |
| Cash at beginning of period | 254.93 Thousand | 748.81 Thousand | 350.84 Thousand | 337.56 Thousand |
| Cash at end of period | 1.1 Million | 251.1 Thousand | 748.81 Thousand | 350.84 Thousand |
| Capital Expenditure | -4.00 | -487.27 Thousand | -1.31 Million | -758.71 Thousand |
| Effect of forex changes on cash | 152.5 Thousand | 522.67 Thousand | 301.76 Thousand | -472.78 Thousand |
| Net cash flow / Change in cash | 850.27 Thousand | -497.71 Thousand | 397.97 Thousand | 13.28 Thousand |
| Free Cash Flow | -4.67 Million | -4.13 Million | 3.23 Million | -1.65 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -997.49 Thousand | 60.03 Thousand | -7.13 Million | -3.69 Million | -2.92 Million | -697.08 Thousand |
| Depreciation & Amortization | 23.08 Thousand | 134.82 Thousand | 680.16 Thousand | 260.47 Thousand | 199.56 Thousand | -18.88 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -45.52 Thousand | 89.15 Thousand | 1.75 Million | 839.39 Thousand | 2.33 Million | 26.15 Thousand |
| Other non-cash items | 733.17 Thousand | -2.00 | 13.89 Thousand | -631.68 Thousand | 990.37 Thousand | 522.28 Thousand |
| Investing Cash Flow | -56.58 Thousand | -270.24 Thousand | - | 7642.00 | -49.00 | 151.8 Thousand |
| Investments in PPE | -56.58 Thousand | -270.24 Thousand | - | 7642.00 | -49.00 | 136.54 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -56.58 Thousand | -270.24 Thousand | - | - | - | 15.26 Thousand |
| Financing Cash Flow | -247.77 Thousand | -641.78 Thousand | 5.37 Million | 4.08 Million | 1.23 Million | -463.88 Thousand |
| Debt repayment | -247.77 Thousand | -1.72 Million | -1.3 Million | -997.19 Thousand | -16.13 Thousand | -266.08 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 5.96 Million | 5.96 Million | - | - |
| Other Financing Activities | 344.4 Thousand | 1.08 Million | 118.88 Thousand | -858.89 Thousand | 1.24 Million | -197.8 Thousand |
| Accounts receivables | -5522.00 | 79.49 Thousand | -1.18 Million | -1.16 Million | -502.6 Thousand | -46.58 Thousand |
| Accounts payables | 395.17 Thousand | -206.53 Thousand | -2.38 Million | -1.62 Million | -212.39 Thousand | 228.01 Thousand |
| Inventory | -202.04 Thousand | -198.32 Thousand | 1.91 Million | 3.12 Million | 179.11 Thousand | -155.25 Thousand |
| Other working capital | -233.13 Thousand | 489.48 Thousand | 3.41 Million | 496.33 Thousand | 2.87 Million | -14.00 |
| Cash at beginning of period | 593.93 Thousand | 1.1 Million | 254.93 Thousand | 90.52 Thousand | 27.64 Thousand | 91.94 Thousand |
| Cash at end of period | 224.08 Thousand | 593.93 Thousand | 1.1 Million | 1.1 Million | 90.52 Thousand | 27.64 Thousand |
| Capital Expenditure | -56.58 Thousand | -270.24 Thousand | - | 7642.00 | -49.00 | 136.54 Thousand |
| Effect of forex changes on cash | 56.73 Thousand | 102.84 Thousand | 152.5 Thousand | 149.66 Thousand | -786.2 Thousand | 415.31 Thousand |
| Net cash flow / Change in cash | -369.84 Thousand | -511.28 Thousand | 850.27 Thousand | 1.01 Million | 62.88 Thousand | -64.3 Thousand |
| Free Cash Flow | -178.81 Thousand | 27.65 Thousand | -4.67 Million | -3.22 Million | -384.63 Thousand | -30.98 Thousand |
PCAR
300380
TOE
BETRF
AUROPHARMA
GSTC